Healthcare Professionals - Product

In this section you will find information on the new product SportVis™ and its use in the treatment of grade I and II ankle sprains.

Please also note that we have developed a 'Patient Information Sheet' for download for your patients (see 'Support') as well as an FAQ section in 'Patients'. There is also a video showing how to administer SportVis™ to a patient with a sprained ankle and another video (See 'About SportVis™' below) showing exact injection technique in a cross sectional manner. If you require further assistance, please contact us.


SportVis packshot

About SportVis™

The main content of SportVis™ is STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid).

SportVis™ is a registered product with the CE mark and both SportVis™ and the manufacturing process for STABHA™ are patented.

SportVis™ is used for treating Grade 1 and 2 ankle sprains. It is administered via a peri-articular injection into the site of injury using the fanning technique. The fanning technique helps to spread SportVis™ over a large surface area within the injury site to enable optimal interaction with the torn ligaments. The fanning technique, as used to administer SportVis™ can be illustrated in the following video link.

How does SportVis™ works?

SportVis™ containing STABHA™ (Soft Tissue Adapted Biocompatible Hyaluronic Acid) has been designed specifically to interact optimally with soft tissue ligaments and tendons due to its purity profile and biocompatibility. When STABHA™ is injected into the site of injury, it reacts rapidly and efficiently with the torn ligaments. The sodium hyaluronate acts as a dynamic supporting feature as it binds to the torn ligamentous fibres, strengthening the fibrin network of the ligaments.

By saturating the injury site with STABHA™, the full potential of its supportive role is achieved.

SportVis™ and R.I.C.E. (Rest, Ice, Compression, Elevation) Standard of Care

SportVis™ is a peri-articular injection that should only be performed by a medical professional trained in the technique. SportVis™ should be injected into the injury site within 48 hours of the injury and the 2nd injection administered 48 hours after the 1st injection.

SportVis™ was designed to be used concurrently with R.I.C.E. to allow the patient to regain range of motion quicker.

Reduces Time to Recovery

A clinical study against placebo (R.I.C.E.) showed that SportVis™ enabled patients to return pain-free and disability-free to sports (and daily activities) 6 days faster than the average 17 days recovery period.

Time to pain-free and disability-free
condition is reduced with SportVis™.
JPG - 92 kb
Pain after walking 20m
Pain after walking 20m is significantly reduced after a treatment with SportVis™.
JPG - 94.8 kb
Pain on weight bearing
Pain on weight bearing is significantly reduced after a treatment with SportVis™.

Improve the Quality of Healing

By achieving the full potential of interaction within the fibrin network of the injured ligaments, enhanced healing quality is possible as SportVis™ is able to strengthen the ankle‚Äôs ligaments during the healing process and reduce scar tissue formation.

Manage Pain and Swelling with very low probability of Systemic Side Effects

Sodium hyaluronate has an ancillary effect of reducing pain and limit inflammation. SportVis™ containing STABHA™ will help reduce the pain and limit inflammation in an ankle sprain due to these ancillary effects with low probability of systemic side effects (none experienced during clinical trials until now).

Reduce Rate of Recurrence

SportVis™ containing STABHA™ can enable the healing process to complete with less scar tissue formation so providing an excellent quality of healing. This allows the ankle to regain its former strength thus reducing the rate of recurrence.